CROSSLINK
Live / Applied — Non-final action mailed (as of 28 Jan 2026)
What this means for you
Not registered yet, but its 02 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99063357
- Mark type
- Stylized text
- Filed
- 02 Mar 2025
- Attorney of record
- Michael Graif
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer
Owner
- Crosslink Therapeutics Inc., Boston, MA, US
Prosecution history
- 28 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jan 2026 — NON-FINAL ACTION E-MAILED
- 28 Jan 2026 — NON-FINAL ACTION WRITTEN
- 25 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 05 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Aug 2025 — NON-FINAL ACTION E-MAILED
- 05 Aug 2025 — NON-FINAL ACTION WRITTEN
- 05 Aug 2025 — ASSIGNED TO EXAMINER
- 02 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 02 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Mar 2025 — NEW APPLICATION ENTERED